Fresenius Medical Care AG & Co. KGaA (FME) Given a €100.80 Price Target at Berenberg Bank

Berenberg Bank set a €100.80 ($117.21) price target on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research note released on Friday. The firm currently has a buy rating on the stock.

FME has been the topic of several other research reports. Deutsche Bank set a €107.00 ($124.42) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a report on Friday, October 5th. Credit Suisse Group set a €75.00 ($87.21) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a report on Wednesday, October 31st. Societe Generale set a €79.00 ($91.86) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a report on Tuesday, November 13th. Morgan Stanley set a €93.00 ($108.14) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a report on Wednesday, November 7th. Finally, UBS Group set a €82.00 ($95.35) target price on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research note on Friday, November 16th. Nine analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. The company presently has an average rating of Buy and an average target price of €89.32 ($103.86).

ETR:FME opened at €69.56 ($80.88) on Friday. Fresenius Medical Care AG & Co. KGaA has a fifty-two week low of €75.53 ($87.83) and a fifty-two week high of €93.82 ($109.09).

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S.

Recommended Story: What are the benefits of a balanced fund?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply